Bioventus Inc. (BVS) vs Jade Biosciences, Inc. (JBIO)
A side-by-side comparison of Bioventus Inc. and Jade Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BVS
Bioventus Inc.
$13.27HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
JBIO
Jade Biosciences, Inc.
$13.53HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
Total return — BVS vs JBIO
growth of $100 · dividends reinvested · last 5yBVS -23.2% (-5.1%/yr)JBIO -97.8% (-53.5%/yr)BVS compounded faster over this window
Log scale — wide-divergence pair
BVS JBIO
BVS vs JBIO: by the numbers
- •BVS is the larger company ($899M vs $823M market cap).
- •BVS is profitable (9.36% net margin) while JBIO runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | BVS | JBIO |
|---|---|---|
| P/E ratio | 17.22 | N/A |
| Forward P/E | 17.04 | N/A |
| P/S ratio | 1.54 | N/A |
| P/B ratio | 3.94 | 1.87 |
| EV / EBITDA | 10.58 | N/A |
| FCF yield | 10.49% | N/A |
Profitability
| Metric | BVS | JBIO |
|---|---|---|
| Gross margin | 68.00% | 0.00% |
| Operating margin | 10.63% | 0.00% |
| Net margin | 9.36% | 0.00% |
| ROE | 23.86% | -34.83% |
| ROIC | 11.37% | -37.39% |
Growth (annualized)
| Metric | BVS | JBIO |
|---|---|---|
| Revenue CAGR (5Y) | 11.82% | N/A |
| EPS CAGR (5Y) | -5.03% | N/A |
| FCF CAGR (5Y) | 43.36% | N/A |
| Total return CAGR (5Y) | -0.81% | -52.65% |
Frequently asked
- Is BVS or JBIO more profitable?
- BVS runs the higher net margin — BVS at 9.36% versus JBIO at 0.00%.
- How have BVS and JBIO total returns compared?
- Over the past 5 years, BVS delivered -0.81% and JBIO delivered -52.65% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bioventus P/E ratioBioventus ROEJade Biosciences ROEBioventus operating marginJade Biosciences operating marginBioventus revenue growthJade Biosciences revenue growthBioventus free cash flowJade Biosciences free cash flow
Bioventus & Jade Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.